Effects of bemiparin on airway responses to antigen in sensitized Brown-Norway rats

European Journal of Pharmacology

Volumn 507, Issue 1-3, 2005, Pages 261-271

  Suchankova, Jana ^a   Mata, Manuel ^a   Cortijo, Julio ^a,b   Morcillo, Esteban J ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

Author keywords

Bemiparin; Brown Norway (rat); Experimental asthma; Fondaparinux

Indexed keywords

ADENOSINE; ANTIGEN; BEMIPARIN; EOSINOPHIL PEROXIDASE; FONDAPARINUX; MUCIN 5AC; SEROTONIN;

AEROSOL; AIRWAY CONSTRICTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANTICOAGULATION; ARTICLE; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; DRUG EFFECT; DRUG SENSITIZATION; ENZYME ACTIVITY; LEUKOCYTE COUNT; LUNG LAVAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN;

ANIMALS; ANTIGENS; ASTHMA; HEPARIN, LOW-MOLECULAR-WEIGHT; IMMUNIZATION; MALE; RATS; RATS, INBRED BN;

EID: 12344337385     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.11.014     Document Type: Article

References (55)

1. 1 receptor blocking agents on anaphylactic response in guinea-pigs Agents Actions 9 1979 467 473
2. T. Ahmed, W.M. Abraham, and J. D'Brot Effects of inhaled heparin on immunologic and nonimmunologic bronchoconstrictor responses in sheep Am. Rev. Respir. Dis. 145 1992 566 570
3. T. Ahmed, C. Campo, M.K. Abraham, J.F. Molinari, W.M. Abraham, D. Ashkin, T. Syriste, L.O. Andersson, and C.M. Svahn Inhibition of antigen-induced acute bronchoconstriction, airway hyperresponsiveness, and mast cell degranulation by a nonanticoagulant heparin: comparison with a low molecular weight heparin Am. J. Respir. Crit. Care Med. 155 1997 1848 1855
4. T. Ahmed, B.J. Gonzalez, and I. Fanta Prevention of exercise-induced bronchoconstriction by inhaled low-molecular-weight heparin Am. J. Respir. Crit. Care Med. 160 1999 576 581
5. T. Ahmed, J. Ungo, M. Zhou, and C. Campo Inhibition of allergic late airway responses by inhaled heparin-derived oligosaccharides J. Appl. Physiol. 88 2000 1721 1729
6. K.A. Bauer, D.W. Hawkins, P.C. Peters, M. Petitou, J.M. Herbert, C.A. van Boeckel, and D.G. Meuleman Fondaparinux, a synthetic pentasaccharide: the first in a new class of antithrombotic agents-the selective factor Xa inhibitors Cardiovasc. Drug Rev. 20 2002 37 52
7. P.A. Becket, and P.H. Howarth Pharmacotherapy and airway remodelling in asthma? Thorax 58 2003 163 174
8. S. Blesa, J. Cortijo, M. Mata, A. Serrano, D. Closa, F. Santangelo, J.M. Estrela, J. Suchankova, and E.J. Morcillo Oral N-acetylcysteine attenuates the rat pulmonary inflammatory response to antigen Eur. Respir. J. 21 2003 394 400
9. C. Campo, J.F. Molinari, J. Ungo, and T. Ahmed Molecular-weight-dependent effects of nonanticoagulant heparins on allergic airway responses J. Appl. Physiol. 86 1999 549 557
10. 1 Thromb. Res. 16 1979 507 516
11. C. Carvalho, S. Jancar, M. Mariano, and P. Sirois A rat model presenting eosinophilia in the airways, lung eosinophil activation, and pulmonary hyperreactivity Exp. Lung Res. 25 1999 303 316
12. B.B. Ceyhan, and T. Celikel Effect of inhaled heparin on adenosine-induced bronchial hyperreactivity Int. J. Clin. Pharmacol. Ther. 35 1997 208 213
13. B.B. Ceyhan, and T. Celikel Effect of inhaled low molecular weight heparin on methacholine-induced bronchoconstriction Int. J. Clin. Pharmacol. Ther. 38 2000 446 451
14. T.M. Chapman, and K.L. Goa Bemiparin. A review of its use in the prevention of venous thromboembolism and treatment of deep vein thrombosis Drugs 63 2003 2357 2377
15. R.A. Coleman Current animal models are not predictive for clinical asthma Pulm. Pharmacol. Ther. 12 1999 87 89
16. J. Cortijo, S. Blesa, M. Martinez-Losa, M. Mata, E. Seda, F. Santangelo, and E.J. Morcillo Effects of taurine on pulmonary responses to antigen in sensitized Brown-Norway rats Eur. J. Pharmacol. 431 2001 111 117
17. M.J. Cushley, A.E. Tattersfield, and S.T. Holgate Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects Br. J. Clin. Pharmacol. 15 1983 161 165
18. A.S. Damazo, W. Tavares de Lima, M. Perretti, and S.M. Oliani Pharmacological modulation of allergic inflammation in the rat airways and association with mast cell heterogeneity Eur. J. Pharmacol. 426 2001 123 130
19. Z. Diamant, and C.P. Page Heparin and related molecules as a new treatment for asthma Pulm. Pharmacol. Ther. 13 2000 1 4
20. M.S. Diamond, R. Alon, C.A. Parkos, M.T. Quinn, and T.A. Springer Heparin is an adhesive ligand for the leukocyte integrin Mac-1 (CD11b/CD1) J. Cell Biol. 130 1995 1473 1482
21. W. Elwood, P.J. Barnes, and K.F. Chung Airway hyperresponsiveness is associated with inflammatory cell infiltration in allergic Brown-Norway rats Int. Arch. Allergy Immunol. 99 1992 91 97
22. J.V. Fahy Goblet cell and mucin gene abnormalities in asthma Chest 122 2002 320S 326S
23. T.K. Ghosh, P.S. Eis, J.M. Mullaney, C.L. Ebert, and D.L. Gill Competitive, reversible, and potent antagonism of inositol 1,4,5-trisphosphate- activated calcium release by heparin J. Biol. Chem. 263 1988 11075 11079
24. W.F. Green, K. Konnaris, and A.J. Woolcock Effect of salbutamol, fenoterol and sodium cromoglycate on the release of heparin from sensitized human lung fragments challenged with Dermatophagoides pteronyssinus antigen Am. J. Respir. Cell Mol. Biol. 8 1993 518 521
25. J.P. Hannon, B. Tigani, I. Williams, L. Mazzoni, and J.R. Fozard Mechanism of airway hyperresponsiveness to adenosine induced by allergen challenge in actively sensitized Brown Norway rats Br. J. Pharmacol. 132 2001 1509 1523
26. D.J. Hele, M.A. Birrell, S.E. Webber, M.L. Foster, and M.G. Belvisi Mediator involvement in antigen-induced bronchospasm and microvascular leakage in the airways of ovalbumin sensitized Brown Norway rats Br. J. Pharmacol. 132 2001 481 488
27. R.E. Howell, and S.L. Woeppel Potential species dependency for the pulmonary antiallergic effects of aerosolized heparin Pulm. Pharmacol. 6 1993 237 239
28. A.D. Jackson Airway goblet-cell mucus secretion Trends Pharmacol. Sci. 22 2001 39 45
29. R. Lever, and C. Page Glycosaminoglycans, airways inflammation and bronchial hyperresponsiveness Pulm. Pharmacol. Ther. 14 2001 249 254
30. R. Lever, W.T. Lo, R.A. Brown, J. Gallaher, and C.P. Page The effects of heparin fractions of defined chain length on human neutrophil functions in vitro Br. J. Pharmacol. 140 2003 (3P)
31. Y. Li, L.D. Martin, M. Minnicozzi, S. Greenfeder, J. Fine, C.A. Petterse, B. Chorley, and K.B. Adler Enhanced expression of mucin genes in a guinea pig model of allergic asthma Am. J. Respir. Cell Mol. Biol. 25 2001 644 651
32. O. Lider, Y.A. Mekori, T. Miller, R. Bar-Tana, I. Vlodavsky, E. Baharav, I.R. Cohen, and Y. Naparstek Inhibition of T lymphocyte heparanase by heparin prevents T cell migration and T cell-mediated immunity Eur. J. Immunol. 20 1990 493 499
33. J. Lucio, J. D'Brot, C.B. Guo, W.M. Abraham, L.M. Lichtenstein, A. Kagey-Sobotka, and T. Ahmed Immunologic mast cell-mediated responses and histamine release are attenuated by heparin J. Appl. Physiol. 73 1992 1093 1101
34. J. Martinez-Salas, R. Mendelssohn, W.M. Abraham, B. Hsiao, and T. Ahmed Inhibition of allergic airway responses by inhaled low-molecular-weight heparins: molecular-weight dependence J. Appl. Physiol. 84 1998 222 228
35. M. Mata, A. Ruiz, M. Cerda, M. Martinez-Losa, J. Cortijo, F. Santangelo, A. Serrano-Mollar, A. Llombart-Bosch, and E.J. Morcillo Oral N-acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats Eur. Respir. J. 22 2003 900 905
36. C.J. Meade, I. Dumont, and L. Worrall Why do asthmatic subjects respond so strongly to inhaled adenosine? Life Sci. 69 2001 1225 1240
37. J.F. Molinari, C. Campo, S. Shakir, and T. Ahmed Inhibition of antigen-induced airway hyperresponsiveness by ultralow molecular-weight heparin Am. J. Respir. Crit. Care Med. 157 1998 887 893
38. T. Nagase, M.J. Dallaire, and M.S. Ludwig Airway and tissue behavior during early response in sensitized rats: role of 5-HT and LTD4 J. Appl. Physiol. 80 1996 583 590
39. D.R. Newman, C.-M. Li, R. Simmons, J. Khosla, and P.L. Sannes Heparin affects signaling pathways stimulated by fibroblast growth factor-1 and -2 in type II cells Am. J. Physiol. 287 2004 L191 L200
40. R. Olivenstein, T. Du, L.J. Xu, and J.G. Martin Microvascular leakage in the airway wall and lumen during allergen induced early and late responses in rats Pulm. Pharmacol. Ther. 10 1997 223 230
41. C.P. Page, and E. Minshall Mast cells and the lung J.C. Foreman The Handbook of Immunopharmacology: Immunopharmacology of Mast Cells and Basophils 1993 Academic Press London 181 195
42. R.A. Pauwels, J.C. Kips, R.A. Peleman, and M.E. Van der Straeten The effect of endotoxin inhalation on airway responsiveness and cellular influx in rats Am. Rev. Respir. Dis. 141 1990 540 545
43. A. Planes Review of bemiparin sodium-a new second-generation low molecular weight heparin and its applications in venous thromboembolism Expert Opin. Pharmacother. 4 2003 1551 1561
44. R. Pons, P. Santamaria, J. Suchankova, J. Cortijo, and E.J. Morcillo Effects of inhaled glaucine on pulmonary responses to antigen in sensitized guinea pigs Eur. J. Pharmacol. 397 2000 187 195
45. J.M. Preuss, and C.P. Page Effect of heparin on antigen-induced airway responses and pulmonary leukocyte accumulation in neonatally immunized rabbits Br. J. Pharmacol. 129 2000 1585 1596
46. M.M. Samama, and G.T. Gerotziafas Evaluation of the pharmacological properties and clinical results of the synthetic pentasaccharide (fondaparinux) Thromb. Res. 109 2003 1 11
47. E.A. Seeds, and C.P. Page Heparin inhibits allergen-induced eosinophil infiltration into guinea-pig lung via a mechanism unrelated to its anticoagulant activity Pulm. Pharmacol. Ther. 14 2001 111 119
48. E.A. Seeds, J. Hanss, and C.P. Page The effect of heparin and related proteoglycans on allergen and PAF-induced eosinophil infiltration J. Lipid Mediat. 7 1993 269 278
49. E.A. Seeds, A.P. Horne, D.J. Tyrrell, and C.P. Page The effect of inhaled heparin and related glycosaminoglycans on allergen-induced eosinophil infiltration in guinea-pigs Pulm. Pharmacol. 8 1995 97 105
50. M. Strath, D.J. Warren, and C.J. Sanderson Detection of eosinophils using an eosinophil peroxidase assay. Its use as an assay for eosinophil differentiation factors J. Immunol. Methods 83 1985 209 215
51. K. Takeyama, K. Dabbagh, H.M. Lee, C. Agusti, J.A. Lausier, I.F. Ueki, K.M. Grattan, and J.A. Nadel Epidermal growth factor system regulates mucin production in airways Proc. Natl. Acad. Sci. U. S. A. 96 1999 3081 3086
52. M.A. Tones, M.D. Bootman, B.F. Higgins, D.A. Lane, G.F. Pay, and U. Lindahl The effect of heparin on the inositol 1,4,5-trisphosphate receptor in rat liver microsomes. Dependence on sulphate content and chain length FEBS Lett. 252 1989 105 108
53. Q.L. Wang, X.Y. Shang, S.L. Zhang, J.B. Ji, Y.N. Cheng, Y.J. Meng, and Y.J. Zhu Effects of inhaled low molecular weight heparin on airway allergic inflammation in aerosol-ovalbumin-sensitized guinea pigs Jpn. J. Pharmacol. 82 2000 326 330
54. C. Weigert, K. Brodbeck, H.U. Häring, G. Gambado, and E.D. Schleicher Low-molecular-weight heparin prevents high glucose- and phorbol ester-induced TGF-β1 gene activation Kidney Int. 60 2001 935 943
55. T. Yahata, Y. Nishimura, H. Maeda, and M. Yokoyama Modulation of airway responsiveness by anionic and cationic polyelectrolyte substances Eur. J. Pharmacol. 434 2002 71 79